跳至主要内容
临床试验/JPRN-UMIN000040147
JPRN-UMIN000040147招募中未知

Subepithelial injection of onabotulinumtoxin A for overactive bladder - Onabotulinumtoxin A injection in overactive bladder

Hokusuikai kinen Hospital Department of Urology0 个研究点目标入组 40 人开始时间: 2020年5月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) The patient has apparent neurogenic diseases causing urinary tract symptoms. 2) The patient underwent treatment with botulinum toxin A. 3) The patient underwent the surgery of lower urinary tract within 1 year. 4) Postvoid residual urine is 100mL or greater. 5) The patient has apparent lower urinary tract obstruction and/or weak detrusor. 6) The patient has predominantly stress urinary incontinence. 7) The patient has active urinary tract infection, malignance and/or bladder stone. 8) The patient is pregnant or breast-feed, or have possibility of such matter within 1 year. 9) The patient is diagnosed as having myasthenia gravis, Lambert-Eaton syndromeconduct , amyotrophic lateral sclerosis. 10)The patient has disturbance of swallowing and/or respiration. 11)The patient has mental and/or cognitive disturbance to conduct the clinical trial. 12) The patient is judged as being unsuitable for the trial by the researcher.

研究者

发起方
Hokusuikai kinen Hospital Department of Urology

相似试验

Subepithelial injection of onabotulinumtoxin A for... | 临床试验